Coloplast A/S (CLPBY)
6.60
+0.14
(+2.17%)
USD |
OTCM |
Oct 09, 16:00
Coloplast Price to Book Value : 7.275 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 7.275 |
| October 08, 2026 | 7.121 |
| October 07, 2026 | 7.066 |
| October 06, 2026 | 7.000 |
| October 05, 2026 | 6.867 |
| October 02, 2026 | 6.812 |
| October 01, 2026 | 6.900 |
| September 30, 2026 | 6.967 |
| September 29, 2026 | 7.066 |
| September 28, 2026 | 7.110 |
| September 25, 2026 | 7.121 |
| September 24, 2026 | 7.099 |
| September 23, 2026 | 7.077 |
| September 22, 2026 | 7.121 |
| September 21, 2026 | 7.132 |
| September 18, 2026 | 7.110 |
| September 17, 2026 | 7.176 |
| September 16, 2026 | 7.110 |
| September 15, 2026 | 7.187 |
| September 14, 2026 | 7.220 |
| September 11, 2026 | 7.242 |
| September 10, 2026 | 7.441 |
| September 09, 2026 | 7.430 |
| September 08, 2026 | 7.683 |
| September 04, 2026 | 7.815 |
| Date | Value |
|---|---|
| September 03, 2026 | 8.025 |
| September 02, 2026 | 8.157 |
| September 01, 2026 | 8.036 |
| August 31, 2026 | 7.870 |
| August 28, 2026 | 7.904 |
| August 27, 2026 | 7.892 |
| August 26, 2026 | 7.870 |
| August 25, 2026 | 8.003 |
| August 24, 2026 | 7.981 |
| August 21, 2026 | 7.584 |
| August 20, 2026 | 7.496 |
| August 19, 2026 | 7.694 |
| August 18, 2026 | 7.485 |
| August 17, 2026 | 7.253 |
| August 14, 2026 | 7.363 |
| August 13, 2026 | 7.396 |
| August 12, 2026 | 7.363 |
| August 11, 2026 | 7.544 |
| August 10, 2026 | 7.330 |
| August 07, 2026 | 7.496 |
| August 06, 2026 | 7.286 |
| August 05, 2026 | 7.385 |
| August 04, 2026 | 7.408 |
| August 03, 2026 | 7.496 |
| July 31, 2026 | 7.385 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ambu A/S | 2.967 |
| Abbott Laboratories | 3.372 |
| AngioDynamics, Inc. | 2.981 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.497 |
Price to Book Value Related Metrics
| PE Ratio | 34.59 |
| PS Ratio | 3.349 |
| Price to Free Cash Flow | 15.48 |
| Price | 6.60 |
| Earnings Yield | 2.89% |
| Market Cap | 13.69B |
| Operating PE Ratio | 12.76 |
| Normalized PE Ratio | 19.15 |